Health Login | Sign Up
This article is expired, comments are disabled.
'You disappointed us': Why is Canada opposing more transparency in drug prices?
Frustration at the pharmaceutical industry's high prices and secrecy bubbled over at the World Health Assembly this week as delegates fought for a strongly-worded resolution calling for greater transparency in the cost of clinical trials, drug R&D and prices. But some countries, including Canada, pushed for softer wording that could maintain secrecy in prices and research.
(C) Canadian Broadcasting Corporation
Share
Home > All News > Health